The 4 NTD-binding, infection-enhancing mAbs were evaluated for additional functionality by measuring their ability to activate FcγRIIIa expressed on reporter cells as a surrogate measure of antibody-dependent cellular cytotoxicity (ADCC). This evidence concerns the gene FCGR3A and infection.